VENTO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 558
EU - Europa 554
AS - Asia 83
Totale 1.195
Nazione #
US - Stati Uniti d'America 556
IE - Irlanda 188
SE - Svezia 174
IT - Italia 91
CN - Cina 56
PL - Polonia 46
DE - Germania 25
IN - India 17
FR - Francia 14
BE - Belgio 7
VN - Vietnam 6
GB - Regno Unito 5
IR - Iran 3
CA - Canada 2
FI - Finlandia 2
AT - Austria 1
HK - Hong Kong 1
UA - Ucraina 1
Totale 1.195
Città #
Chandler 212
Dublin 186
Nyköping 125
Ashburn 47
Warsaw 46
Messina 36
Princeton 34
Medford 25
Bremen 24
Des Moines 20
Dearborn 13
Ann Arbor 12
Hyderabad 12
Beijing 11
Rome 11
Jacksonville 9
Jinan 9
Brussels 7
Nanjing 7
Dong Ket 6
Hangzhou 5
Tianjin 5
Nanchang 4
Redwood City 4
Seattle 4
Waverly Hall 4
Florence 3
Pune 3
Santa Domenica 3
Torregrotta 3
Wilmington 3
Augusta 2
Fiumefreddo Di Sicilia 2
Helsinki 2
Padova 2
Pozzo Di Gotto 2
Taizhou 2
Berlin 1
Boardman 1
Cambridge 1
Castelnuovo Rangone 1
Castelvetrano 1
Changsha 1
Chengdu 1
Duncan 1
Edinburgh 1
Fairfield 1
Fuzhou 1
Hong Kong 1
Houston 1
Lanzhou 1
Leawood 1
Los Angeles 1
Maple Ridge 1
Monserrato 1
Ningbo 1
Ottawa 1
Palermo 1
Pescara 1
Qingdao 1
San Mateo 1
Santa Teresa Di Riva 1
Shenyang 1
Shenzhen 1
Taiyuan 1
Vienna 1
Vittoria 1
Washington 1
Wuhan 1
Zhengzhou 1
Totale 938
Nome #
PRRT Retreatments: Renal Function Evaluation 86
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 77
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 65
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 63
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 62
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 59
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 58
Renal Function Evaluation in PRRT Retreatments 57
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 54
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 52
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 51
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 49
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 46
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 45
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 44
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 44
PRRT retreatments: renal function evaluation 42
One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy 42
The utility of dual time-point FET-PET/CT in recurrence assessment of glioma patients 41
Artifcial intelligence applications in SSTR targeted PET/CT images: prediction of response assessment in GEP-NETs undergoing PRRT with [177Lu]DOTATOC 41
Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience 36
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 31
Artificial intelligence applications in 68Ga-DOTA PETICT images: Prediction of response assessment in GEP-NETs undergoing PRRT with 177Lu-DOTATOC 31
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 23
null 23
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 20
Response prediction to PRRT in progressing and metastatic GEP-NET undergoing restaging 68Ga-DOTA PETICT: A preliminary multicenter radiomics study 10
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study 1
Totale 1.253
Categoria #
all - tutte 5.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 4 0
2019/202058 1 0 0 3 0 11 5 4 2 11 4 17
2020/2021173 12 5 45 6 20 12 12 14 18 11 9 9
2021/2022236 1 13 2 10 20 1 21 21 3 27 22 95
2022/2023652 57 93 28 61 48 60 8 48 229 5 12 3
2023/2024120 13 16 7 10 18 24 9 10 0 13 0 0
Totale 1.253